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Abstract
Schwann cells ensheath all axons of peripheral nerves. Only around large-diameter axons do they
elaborate myelin, forming insulating sheaths that are vital for fast conduction of axon potentials.
A series of recent papers has illuminated some of the ways in which the process of myelination is
controlled, both by signals from axons and by positive and negative transcriptional mechanisms within
the Schwann cells themselves.
Introduction and context
It has long been known that axonal signals control the
induction and maintenance of the Schwann cell myelin
sheath that surrounds the large-diameter axons in
peripheral nerves. However, until very recently, the
nature of these signals has remained obscure. In contrast,
the identity of the transcription factors in Schwann cells
that organise the myelination programme is much better
characterised. Well-established transcriptional regulators
of this programme include Krox-20 (early growth
response gene 2, or Egr-2) and its associated proteins,
NAB (nucleic acid-binding protein) 1 and 2, Sox-10,
Oct-6 and Brn1 and Brn2. Current knowledge of the
mechanisms by which these factors exert their effects on
myelination has recently been reviewed [1].
Unlike most other cell types, Schwann cells can readily
dedifferentiate. Thus, when myelinating Schwann cells
are deprived of axonal contact in injured nerves, they
adopt a molecular and morphological phenotype that is
similar, though not identical, to the phenotype of
immature Schwann cells prior to myelination. Depend-
ing on circumstances, therefore, Schwann cells either
provide support for mature axons by elaboration of a
myelin sheath or provide an environment through which
axons can regrow after injury and subsequently remye-
linate. We are just beginning to form a more compre-
hensive picture of how Schwann cells transit between
these two phenotypes, with an emerging picture of a
mechanism involving cross-inhibitory interactions
between positive and negative transcriptional regulators
of myelination [2].
An important advance in our understanding of axonal
signalling mechanisms that control myelination has
occurred in the past five years. Several papers have
shown that the axonal surface protein neuregulin 1
(type IIIb1), acting via its receptors ErbB2 and ErbB3,
controls the thickness of the Schwann cell myelin sheath
and is part of the mechanism that controls the expression
of myelin genes and the induction of myelination [3-7].
This factor also controls the survival of Schwann cell
precursors and is a potent mitogen for Schwann cell
precursors and Schwann cells. It remains a challenge to
understand the mechanism by which the Schwann cell
switches its response to neuregulin from a non-myelinat-
ing proliferative phase to a non-proliferative myelination
mode. Some evidence suggests that a balance between
ERK (extracellular signal-related kinase) 1/2 and JNK
(c-Jun N-terminal kinase)/c-Jun (pro-dedifferentiation)
andPI3kinase(phosphatidylinositol-3kinase)/AKT(pro-
myelination) signalling may be involved, but the picture
is far from clear [8-12]. To add complications, soluble
neuregulin isoforms at high concentrations can also
promote demyelination [13]. Although neuregulin is
required in peripheral nervous system myelination, it is
not required for myelination by oligodendrocytes in the
central nervous system [14].
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Recent evidence suggests that neuregulin 1 type III
expressed by axons also regulates the formation of
mature non-myelinating Schwann cells (Remak bun-
dles). Genetic inactivationofneuregulin 1typeIII insmall-
calibre unmyelinated C-fibres, using Nav1.8-Cre mice,
results in aberrant Remak fibres that contain abnormally
large numbers of axons, and the altered morphology is
reflected in a reduced response to noxious pressure
stimulation [15]. In these mice, neuregulin 1 type III was
also inactivated in small myelinated Ad fibres. This
resulted in an increase in the number of axons in this size
category which remained unmyelinated, despite achiev-
ing a 1:1 relationship with Schwann cells. This is in line
with earlier evidence that neuregulin 1 type III promotes
myelination, as discussed above. Despite the altered
morphology, the nerves of these mutant mice contain
normal numbers of axons and Schwann cells.
One of the ways in which neuregulin signalling is likely to
control myelination is by increasing the Ca
2+ level in
Schwann cells. This activates the phosphatase calcineurin,
which dephosphorylates nuclear factor of activated T cells
(NFAT)c3andc4,resultingintranslocationtothenucleus.
Kao and colleagues [16] show that deleting calcineurin B
specifically in the Schwann cell lineage results in defects in
radial sorting and hypomyelination in newborn mice.
Becausethemicedieshortlyafterbirth,itisnotpossibleto
say whether the hypomyelination is transient or perma-
nent. Lack of calcineurin B prevents neuregulin-induced
dephosphorylation and activation of NFAT c3 and c4.
Furthermore, NFAT c4 complexes withSox-10, a transcrip-
tion factor required for myelination [17], to activate the
promoter and myelin-specific enhancer of the Krox-20
gene, which globally regulates peripheral myelination
[11,18-20], and also with the promoter of the myelin
protein zero (P0) gene, all of which underline the
involvement of NFAT proteins in myelination.
It has long been known that elevation of intracellular
cyclic AMP levels induces cultured Schwann cells to
express myelin proteins and adopt many other aspects of
the myelinating Schwann cell phenotype, suggesting that
cAMP is part of the signalling system that promotes
myelination [21]. A recent paper now provides important
in vivo evidence for this proposition [22]. In experiments
using mutant zebrafish, the authors found that the
G protein-coupled receptor GPR126 is essential for
myelination in the peripheral nervous system and that
the defect is confined to signalling within Schwann cells
rather than axons. Significantly, treatment of the develop-
ingmutantfishwithforskolin,which elevatesintracellular
cAMP levels, restores myelination, suggesting that this
orphan receptor acts by controlling Schwann cell cAMP
levels. Because levels of neuregulin and ErbB3 receptors
remain normal in the mutant fish, it is likely that GPR126
functions independently of neuregulin to regulate myeli-
nation. Additional evidence for the involvement of cAMP
and cAMP-dependent protein kinase A (PKA) in myelina-
tioncomes from studies of the transcriptionfactor nuclear
factor-kappa-B (NF-kB) [23]. In Schwann cell-dorsal root
ganglion (DRG) co-cultures, inhibition of NF-kB activa-
tion inhibits proper association of Schwann cells with
axons and myelination, and co-cultures using cells from
micelackingthep65activesubunitofNF-kBshowmarked
inhibition of myelination [24]. Significantly, phosphor-
ylationofthep65subunitbyPKAincreasestranscriptional
activity but not DNA binding and is required for
upregulationofOct-6bycAMP.Althoughtheexperiments
remain to be confirmed in vivo, the results suggest that this
factor transduces cAMP signals within Schwann cells and
promotes myelination at early stages of myelin induction.
Linking these findings to those from zebrafish, it may also
be significant that there are two binding sites for NF-kB
within the GPR126 promoter.
Cell-cellinteractionsbetweenaxonsandSchwanncellsare
vital to the process of myelination. Two recent papers
reveal new roles for nectin-like cell adhesion molecules
(Necls), members of the immunoglobulin superfamily of
cell adhesion molecules, at the onset of myelination
[25,26]. Necl2 and Necl4 are expressed in Schwann cell
membranes, principally in the internodal region and in
Schmidt-Lanterman incisures while Necl1 and Necl2 are
expressed by axons. Necl4 interacts heterophilically with
Necl1, expressed on axons, to facilitate myelination.
Knockdown of Necl4 by shRNA (short hairpin RNA)
severely inhibits myelination in DRG-Schwann cell co-
cultures. Although Schwann cells can line up along the
axons and even enclose them, they fail to make even 1.5
turns around the axons, pointing to a requirement for
these proteins at the early stages of myelination to ensure
proper wrapping and spiralling of the Schwann cell
membrane. In addition, levels of the transcription factors
Oct-6 and Krox-20 remain low in these co-cultures. It
remains to be determined, however, whether this pheno-
type will be reproduced by knockout of Necl4 in vivo.
In addition to transcription factors that promote myelina-
tion, such as NFAT, NF-kB, Sox-10, Krox-20 and Oct-6
(discussed above),thereisincreasingevidencethatmyelin
differentiation is subject to negative transcriptional
regulation. In vivo, selective inactivation of Notch 1 in
Schwann cells accelerates myelination while overexpres-
sion of the active intracellular domain of Notch (NICD)
delays it, indicating that myelination is negatively
controlled by Notch signalling [27]. The major role of
negative regulation is likely to be that of driving Schwann
cell demyelination/dedifferentiation. NICD levels rise
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is slower if the NICD elevation is prevented. Conversely,
demyelination is accelerated in injured nerves engineered
to overexpress NICD. Even in uninjured nerves, activation
of Notch is sufficient to induce rapid demyelination [27].
Anothertranscriptionregulator,c-Jun,is similarlyelevated
in the Schwann cells of injured nerves, and as with
Notch 1, demyelination is delayed when this elevation is
prevented [12]. c-Jun is also required for the generation of
the characteristic molecular and morphological pheno-
type of the dedifferentiated cell [28]. Other transcription
factors that negatively regulate myelin differentiation in
cell culture include Sox2 and Id2 and Id4 [2,29].
Future directions
Lipids form major components of the myelin sheath and
wearejustbeginningtoexplorehowmyelinlipidsynthesis
is synchronised with that of the myelin proteins [30-32].
ThepathwaysactivatedbyestablishedSchwanncellsignals,
such as cAMP and neuregulin, are actively being clarified as
exemplifiedbytheworkonGPR126andNF-kBmentioned
aboveandbytherecentidentificationofBACE1(b-siteAPP
cleaving enzyme), the PDZ (post-synaptic density 95-discs
large-zonula occludens 1) domain protein erbin and the
tyrosine phosphatase Shp2 (src homology 2 domain-
containing protein tyrosine phosphatase 2) as participants
in neuregulin signalling and myelination [33-36]. The
downstream targets of novel Schwann cell signalling
molecules (for example, the Necl proteins) will also have
to be determined. We can expect to learn more about the
role of epigenetic mechanisms in myelination and to
understand more about how positive and negative
transcriptional regulators of myelination are integrated at
the molecular level and how they exert control over the
promoter regions, intronic elements and downstream
elements of myelin genes [1].
The mechanisms that control radial sorting and the
generation of the pro-myelin cell, a prerequisite for
myelination, are the focus of extremely active investiga-
tion outside the scope of this commentary. Rapid
progress can be expected in this field in the near future.
Surprisingly, recent work shows that normal prion
protein is involved in the control of myelin maintenance.
Ablation of this prion protein in mice results in a chronic
demyelinating neuropathy, although myelin is initially
formed normally. The authors show that depletion of
prion protein in neurons but not Schwann cells triggers
the neuropathy, and that cleavage of the protein at the
amino terminal end is required. It remains to be
determined whether axonal prion protein interacts
directly with Schwann cells or whether this protein
affects myelin maintenance indirectly [37].
Abbreviations
DRG, dorsal root ganglion; GPR126, G protein-coupled
receptor 126; Necl, nectin-like cell adhesion molecule;
NF-kB, nuclear factor-kappa-B; NFAT, nuclear factor of
activated Tcells; NICD,Notch intracellular domain;PKA,
protein kinase A.
Competing interests
The authors declare that they have no competing
interests.
Acknowledgements
The authors are supported by a programme grant from
the Wellcome Trust, and a project grant from the Medical
Research Council of Great Britain. The research leading
to results from our laboratory has also received funding
from the European Community’s Seventh Framework
Programme (FP7/2007-2013) under grant agreement
HEALTH-F2-2008-201535.
References
1. Svaren J, Meijer D: The molecular machinery of myelin gene
transcription in Schwann cells. Glia 2008, 56:1541-51.
2. Jessen KR, Mirsky R: Negative regulation of myelination:
relevance for development, injury and demyelinating disease.
Glia 2008, 56:1552-65.
3. Garratt AN, Voiculescu O, Topilko P, Charnay P, Birchmeier C:
A dual role of erbB2 in myelination and in expansion of the
schwann cell precursor pool. J Cell Biol 2000, 148:1035-46.
4. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B,
Birchmeier C, Role L, Lai C, Schwab MH, Nave KA: Axonal
neuregulin-1 regulates myelin sheath thickness. Science 2004,
304:700-3.
f1000 Factor 3.2 Recommended
Evaluated by Elior Peles 06 Apr 2004, Manzoor Bhat 19 May 2004
5. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S,
Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L,
Salzer JL: Neuregulin-1 type III determines the ensheathment
fate of axons. Neuron 2005, 47:681-94.
f1000 Factor 4.8 Must Read
EvaluatedbyBrianPopko14Sep2005,Klaus-ArminNave19Sep2005
6. Chen S, Velardez MO, Warot X, Yu ZX, Miller SJ, Cros D, Corfas G:
Neuregulin 1-erbbB signalling is necessary for normal
myelination and sensory function. J Neurosci 2006, 26:3079-86.
7. Lyons DA, Pogoda HM, Voas MG, Woods IG, Daimond B, Nix R,
Arana N, Jacobs J, Talbot WS: erbB3 and erbB2 are essential for
Schwann cell migration and myelination in zebrafish. Curr Biol
2005, 15:513-24.
8. Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS,
Mudge AW, Lloyd AC: The Ras/Raf/ERK signaling pathway
drives Schwann cell dedifferentiation. EMBO J 2004, 23:3061-71.
9. Maurel P, Salzer JL: Axonal regulation of Schwann cell
proliferation and survival and the initial events of myelination
requires PI 3-kinase activity. J Neurosci 2000, 20:4635-45.
10. Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H,
Nakamura K, Tanaka S: Opposing extracellular signal-regulated
kinase and Akt pathways control Schwann cell myelination.
J Neurosci 2004, 24:6724-32.
11. Parkinson DB, Bhaskaran A, Droggiti A, Dickinson S, D’Antonio M,
Mirsky R, Jessen KR: Krox-20 inhibits Jun-NH2-terminal kinase/
Page 3 of 4
(page number not for citation purposes)
f1000 Biology Reports 2010, 2:19 http://f1000.com/reports/biology/content/2/19c-Jun to control Schwann cell proliferation and death. J Cell Biol
2004, 164:385-94.
12. Parkinson DB, Bhaskaran A, Arthur-Farraj P, Nonn LA, Woodhoo A,
Lloyd AC, Feltri ML, Wrabetz L, Behrens A, Mirsky R, Jessen KR:
c-Jun is a negative regulator of myelination. J Cell Biol 2008,
181:625-37.
f1000 Factor 3.0 Recommended
Evaluated by Chaya Kalcheim 04 Jun 2008
13. Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA: Micro-
anatomy of axon/glial signaling during Wallerian degenera-
tion. J Neurosci 2005, 25:3478-87.
14. Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Müller T,
Wende H, Stassart RM, Nawaz S, Humml C, Velanac V, Radyushkin K,
Goebbels S, Fischer TM, Franklin RJ, Lai C, Ehrenreich H,
Birchmeier C, Schwab MH, Nave KA: Neuregulin-1/ErbB signaling
serves distinct functions in myelination of the peripheral and
central nervous system. Neuron 2008, 59:581-95.
f1000 Factor 9.0 Exceptional
Evaluated by Rhona Mirsky 29 Sep 2008
15. Fricker FR, Zhu N, Tsantoulas C, Abrahamsen B, Nassar MA,
Thakur M, Garratt AN, Birchmeier C, McMahon SB, Wood JN,
Bennett DL: Sensory axon-derived neuregulin-1 is required for
axoglial signaling and normal sensory function but not for
long-term axon maintenance. J Neurosci 2009, 29:7667-78.
f1000 Factor 6.0 Must Read
Evaluated by Rhona Mirsky 14 Jul 2009
16. Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA, Crabtree GR:
Calcineurin/NFATsignalingisrequiredforneuregulin-regulated
Schwann cell differentiation. Science 2009, 323:651-4.
f1000 Factor 6.4 Must Read
Evaluated by Raymond Harris 22 Apr 2009, Klaus-Armin Nave
06 Mar 2009
17. Schreiner S, Cossais F, Fischer K, Scholz S, Bösl MR, Holtmann B,
Sendtner M, Wegner M: Hypomorphic Sox10 alleles reveal
novel protein functions and unravel developmental differ-
ences in glial lineages. Development 2007, 134:3271-81.
18. Topilko P, Schneider-Manoury S, Levi G, Baron-Van Evercooren A,
Chennoufi ABY, Seitanidou T, Babinet C, Charnay P: Krox-20
controls myelination in the peripheral nervous system. Nature
1994, 371:796-9.
19. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J: EGR2
mutations in inherited neuropathies dominant-negatively
inhibit myelin gene expression. Neuron 2001, 30:355-68.
20. Ghislain J, Charnay P: Control of myelination in Schwann cells:
a Krox20 cis-regulatory element integrates Oct6, Brn2 and
Sox10 activities. EMBO Rep 2006, 7:52-8.
21. Mirsky R, Jessen KR: Molecular signalling in Schwann cell
development. In Peripheral Neuropathy. Vol. 1. 4th edition. Edited by
Dyck PJ, Thomas PK. Philadelphia: Elsevier Saunders; 2005:341-376.
22. Monk KR, Naylor SG, Glenn TD, Mercurio S, Perlin JR, Dominguez C,
Moens CB, Talbot WS: A G protein-coupled receptor is
essential for Schwann cells to initiate myelination. Science
2009, 325:402-5.
f1000 Factor 6.0 Must Read
Evaluated by Klaus-Armin Nave 16 Sep 2009
23. Yoon C, Korade Z, Carter BD: Protein kinase A-induced
phosphorylation of the p65 subunit of nuclear factor-kappaB
promotes Schwann cell differentiation into a myelinating
phenotype. J Neurosci 2008, 28:3738-46.
24. Nickols JC, Valentine W, Kanwal S, Carter BD: Activation of the
transcription factor NF-kappaB in Schwann cells is required
for peripheral myelin formation. Nat Neurosci 2003, 6:161-7.
f1000 Factor 3.0 Recommended
Evaluated by Elior Peles 04 Feb 2003
25. Maurel P, Einheber S, Galinska J, Thaker P, Lam I, Rubin MB, Scherer SS,
Murakami Y, Gutmann DH, Salzer JL: Nectin-like proteins mediate
axon Schwann cell interactions along the internode and are
essential for myelination. J Cell Biol 2007, 178:861-74.
f1000 Factor 3.3 Recommended
Evaluated by Vance Lemmon 12 Sep 2007, Rhona Mirsky 18 Sep
2007, Yoshimi Takai 11 Oct 2007
26. Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, Sarig-Nadir O,
Horresh I, Scherer SS, Rasband MN, Peles E: A central role for
Necl4 (SynCAM4) in Schwann cell-axon interaction and
myelination. Nat Neurosci 2007, 10:861-9.
f1000 Factor 6.5 Must Read
Evaluated by Brian Popko 19 Jun 2007, Klaus-Armin Nave 25 Jun
2007, Rhona Mirsky 19 Sep 2007
27. Woodhoo A, Alonso MB, Droggiti A, Turmaine M, D’Antonio M,
Parkinson DB, Wilton DK, Al-Shawi R, Simons P, Shen J, Guillemot F,
Radtke F, Meijer D, Feltri ML, Wrabetz L, Mirsky R, Jessen KR: Notch
controls embryonic Schwann cell differentiation, postnatal
myelination and adult plasticity. Nat Neurosci 2009, 12:839-47.
f1000 Factor 6.0 Must Read
Evaluated by Brian Popko 18 Jun 2009
Glia 2009, 57:S158. Poster
29. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, Milbrandt J:
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves
identifies Sox2 as an inhibitor of Schwann cell differentiation
and myelination. Proc Natl Acad Sci U S A 2005, 102:2596-601.
30. Leblanc SE, Srinivasan R, Ferri C, Mager GM, Gillian-Daniel AL,
Wrabetz L, Svaren J: Regulation of cholesterol/lipid biosynthetic
genes by Egr2/Krox20 during peripheral nerve myelination.
J Neurochem 2005, 93:737-48.
31. Saher G, Quintes S, Möbius W, Wehr MC, Krämer-Albers EM,
Brügger B, Nave KA: Cholesterol regulates the endoplasmic
reticulum exit of the major membrane protein P0 required
for peripheral myelin compaction. J Neurosci 2009, 29:6094-104.
32. Verheijen MH, Camargo N, Verdier V, Nadra K, de Preux Charles AS,
Médard JJ, Luoma A, Crowther M, Inouye H, Shimano H, Chen S,
Brouwers JF, Helms JB, Feltri ML, Wrabetz L, Kirschner D, Chrast R,
Smit AB: SCAP is required for timely and proper myelin
membrane synthesis. Proc Natl Acad Sci U S A 2009, 106:21383-8.
33. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R:
Bace1 modulates myelination in the central and peripheral
nervous system. Nat Neurosci 2006, 9:1520-5.
34. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A,
DeStrooper B, Saftig P, Birchmeier C, Haass C: Control of
peripheral nerve myelination by the beta-secretase BACE1.
Science 2006, 314:664-6.
f1000 Factor 3.2 Recommended
EvaluatedbyKlaus-ArminNave16Oct2006,BrianPopko01Nov2006
35. Tao Y, Dai P, Liu Y, Marchetto S, Xiong W-C, Borg J-P, Mei L: Erbin
regulates NRG1 signaling and myelination. Proc Natl Acad Sci
USA2009, 106:9477-82.
f1000 Factor 3.0 Recommended
Evaluated by Kristjan R Jessen 10 Jun 2009
36. Grossmann KS, Wende H, Paul FE, Cheret C, Garratt AN, Zurborg S,
Feinberg K, Besser D, Schulz H, Peles E, Selbach M, Birchmeier W,
Birchmeier C: The tyrosine phosphatase Shp2 (PTPN11)
directs Neuregulin-1/ErbB signaling throughout Schwann
cell development. Proc Natl Acad Sci U S A 2009, 106:16704-9.
37. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P,
Steele AD, Toyka KV, Nave KA, Weis J, Aguzzi A: Axonal prion
protein is required for peripheral myelin maintenance. Nat
Neurosci 2010, 13:310-8.
Page 4 of 4
(page number not for citation purposes)
f1000 Biology Reports 2010, 2:19 http://f1000.com/reports/biology/content/2/19
Mirsky R, Raivich G, Jessen KR: Schwann cell c-Jun is essential
28. Wilton D, Arthur-Farraj P, Latouche M, Turmaine M, Behrens A,
for peripheral nerve regeneration.
542.